Calcium Channel Blocker Flops in Parkinson’s Disease Trial

Calcium Channel Blocker Flops in Parkinson’s Disease Trial
PHILADELPHIA -- An anti-hypertensive drug failed to outperform placebo in slowing Parkinson's disease progression, results from the highly-anticipated STEADY-PD III trial indicated. No significant ... read more
Source: Bing NewsPublished on 2019-05-02